Coave Therapeutics

About:

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Website: https://coavetx.com

Top Investors: Bpifrance, eureKARE, Kurma Partners, Omnes Capital, The ALS Association

Description:

Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.

Total Funding Amount:

79.1M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2014-01-01

Contact Email:

contact(AT)coavetx.com

Founders:

Denis Cayet, Guylène Le Meur, Michel Weber, Philippe Moullier

Number of Employees:

1-10

Last Funding Date:

2024-02-16

IPO Status:

Private

Industries: